FOLR1 and glioblastoma: Results showed that the folate-modified iron oxide NPs exerted substantial effects on U87MG and P3#GBM cells but had limited effects on normal human astrocytes, likely due to higher expression of folate receptor 1 and folate receptor beta in GBM cells.